Yasuhide Masuhara

Title: Yasuhide Masuhara: Innovator in Cancer Treatment

Introduction

Yasuhide Masuhara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic technologies. His work focuses on enhancing the efficacy of cancer treatments using advanced cellular technologies.

Latest Patents

Masuhara holds a patent for a novel invention titled "NY-ESO-1-containing artificial adjuvant vector cell for use in treatment of cancer." The objective of this invention is to provide clinically applicable aAVC-NY-ESO-1 cells that stably express NY-ESO-1. These cells are designed for use in treating patients with NY-ESO-1-expressing cancers. The invention includes a human-derived cell that comprises a polynucleotide encoding CD1d and a polynucleotide encoding NY-ESO-1 or a fragment thereof, with the latter operably linked to an inducible promoter.

Career Highlights

Throughout his career, Yasuhide Masuhara has worked with notable organizations, including Riken Corporation and Astellas Pharma GmbH. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapies.

Collaborations

Masuhara has collaborated with esteemed colleagues such as Keisuke Ohsumi and Ayaka Akiba. These partnerships have fostered a collaborative environment that promotes innovation and the advancement of cancer treatment technologies.

Conclusion

Yasuhide Masuhara's contributions to cancer treatment through his innovative patent and collaborations with leading experts highlight his role as a significant figure in the field of medical research. His work continues to pave the way for advancements in cancer therapies.